FDA shares research to improve dose selection in pediatric drug development
Regulatory NewsMary Ellen Schneider
Clinical TrialsFDA meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsMary Ellen SchneiderClinical TrialsFDA meeting and communication strategyNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy